Concepts (153)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Colon | 4 | 2020 | 496 | 1.240 |
Why?
|
| Pluripotent Stem Cells | 2 | 2022 | 31 | 1.040 |
Why?
|
| Human Embryonic Stem Cells | 2 | 2019 | 5 | 0.850 |
Why?
|
| Tissue Engineering | 3 | 2019 | 181 | 0.820 |
Why?
|
| Cell-Derived Microparticles | 1 | 2021 | 11 | 0.810 |
Why?
|
| Exosomes | 1 | 2021 | 50 | 0.770 |
Why?
|
| Extracellular Vesicles | 1 | 2021 | 42 | 0.760 |
Why?
|
| Organoids | 4 | 2020 | 61 | 0.700 |
Why?
|
| Neuroendocrine Cells | 1 | 2019 | 3 | 0.690 |
Why?
|
| Bioartificial Organs | 1 | 2019 | 2 | 0.690 |
Why?
|
| Regenerative Medicine | 1 | 2019 | 23 | 0.670 |
Why?
|
| Lab-On-A-Chip Devices | 1 | 2018 | 23 | 0.650 |
Why?
|
| Receptors, CCR | 2 | 2015 | 4 | 0.640 |
Why?
|
| Colorectal Neoplasms | 3 | 2017 | 938 | 0.640 |
Why?
|
| Coculture Techniques | 1 | 2018 | 164 | 0.640 |
Why?
|
| Tissue Scaffolds | 1 | 2019 | 106 | 0.620 |
Why?
|
| Small Cell Lung Carcinoma | 1 | 2019 | 98 | 0.620 |
Why?
|
| Extracellular Matrix | 1 | 2019 | 232 | 0.600 |
Why?
|
| Adenomatous Polyposis Coli Protein | 2 | 2017 | 40 | 0.600 |
Why?
|
| Lung | 6 | 2022 | 1170 | 0.560 |
Why?
|
| Liver Neoplasms, Experimental | 1 | 2015 | 27 | 0.530 |
Why?
|
| Colonic Neoplasms | 2 | 2016 | 556 | 0.510 |
Why?
|
| Liver | 2 | 2020 | 1230 | 0.480 |
Why?
|
| Stem Cells | 3 | 2021 | 351 | 0.450 |
Why?
|
| Intestinal Mucosa | 1 | 2018 | 797 | 0.450 |
Why?
|
| Neoplasm Proteins | 1 | 2016 | 532 | 0.440 |
Why?
|
| Chemokines, CC | 1 | 2012 | 34 | 0.430 |
Why?
|
| Gene Expression Profiling | 2 | 2017 | 1384 | 0.400 |
Why?
|
| Disease Models, Animal | 2 | 2021 | 2232 | 0.360 |
Why?
|
| Neoplasms | 2 | 2021 | 2898 | 0.320 |
Why?
|
| Receptors, Notch | 3 | 2019 | 120 | 0.320 |
Why?
|
| Lung Neoplasms | 1 | 2019 | 2262 | 0.280 |
Why?
|
| Gene Expression Regulation, Neoplastic | 3 | 2019 | 1197 | 0.280 |
Why?
|
| Mice, Inbred NOD | 2 | 2019 | 187 | 0.270 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2019 | 458 | 0.270 |
Why?
|
| Signal Transduction | 2 | 2015 | 3241 | 0.270 |
Why?
|
| Adenocarcinoma | 1 | 2012 | 1169 | 0.260 |
Why?
|
| Cells, Cultured | 2 | 2019 | 2818 | 0.210 |
Why?
|
| Humans | 16 | 2022 | 86644 | 0.210 |
Why?
|
| Adrenoleukodystrophy | 1 | 2021 | 3 | 0.210 |
Why?
|
| Induced Pluripotent Stem Cells | 2 | 2020 | 104 | 0.200 |
Why?
|
| Single-Cell Analysis | 2 | 2021 | 134 | 0.200 |
Why?
|
| MicroRNAs | 2 | 2016 | 534 | 0.190 |
Why?
|
| Tropism | 1 | 2020 | 4 | 0.190 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2020 | 104 | 0.190 |
Why?
|
| Organogenesis | 2 | 2020 | 41 | 0.190 |
Why?
|
| Cell Line, Tumor | 3 | 2016 | 2426 | 0.180 |
Why?
|
| Macrophages | 1 | 2022 | 554 | 0.170 |
Why?
|
| Retinoblastoma Protein | 1 | 2019 | 66 | 0.170 |
Why?
|
| Urea | 1 | 2018 | 57 | 0.160 |
Why?
|
| Hep G2 Cells | 1 | 2018 | 48 | 0.160 |
Why?
|
| Animals | 8 | 2021 | 26582 | 0.160 |
Why?
|
| Caco-2 Cells | 1 | 2018 | 123 | 0.160 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2019 | 154 | 0.160 |
Why?
|
| Mice | 6 | 2021 | 11352 | 0.160 |
Why?
|
| Albumins | 1 | 2018 | 133 | 0.160 |
Why?
|
| Adenomatous Polyposis Coli | 1 | 2017 | 39 | 0.150 |
Why?
|
| Tumor Cells, Cultured | 1 | 2019 | 1041 | 0.150 |
Why?
|
| Betacoronavirus | 1 | 2020 | 258 | 0.150 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2017 | 114 | 0.140 |
Why?
|
| Cell-Free System | 1 | 2016 | 51 | 0.140 |
Why?
|
| Antiviral Agents | 1 | 2020 | 510 | 0.140 |
Why?
|
| Genes, Neoplasm | 1 | 2016 | 37 | 0.140 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2019 | 381 | 0.140 |
Why?
|
| Asymmetric Cell Division | 1 | 2016 | 2 | 0.140 |
Why?
|
| ErbB Receptors | 1 | 2019 | 485 | 0.140 |
Why?
|
| Blastocyst | 1 | 2015 | 34 | 0.130 |
Why?
|
| Adenoma | 1 | 2017 | 235 | 0.130 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 316 | 0.130 |
Why?
|
| Biomarkers | 1 | 2021 | 1718 | 0.130 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 301 | 0.130 |
Why?
|
| RNA, Long Noncoding | 1 | 2016 | 102 | 0.130 |
Why?
|
| Biomimetics | 1 | 2014 | 29 | 0.120 |
Why?
|
| Cell Division | 1 | 2016 | 696 | 0.120 |
Why?
|
| Carcinogenesis | 1 | 2016 | 195 | 0.120 |
Why?
|
| Neoplastic Stem Cells | 1 | 2016 | 143 | 0.120 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2015 | 179 | 0.120 |
Why?
|
| Cell Proliferation | 2 | 2017 | 1578 | 0.120 |
Why?
|
| Models, Biological | 1 | 2020 | 1749 | 0.110 |
Why?
|
| Transcription Factor HES-1 | 1 | 2012 | 7 | 0.110 |
Why?
|
| Nerve Tissue Proteins | 1 | 2016 | 503 | 0.110 |
Why?
|
| Mutation | 2 | 2021 | 3968 | 0.110 |
Why?
|
| Chemotaxis | 1 | 2012 | 72 | 0.110 |
Why?
|
| Mice, SCID | 1 | 2012 | 252 | 0.100 |
Why?
|
| Neoplasm Transplantation | 1 | 2012 | 391 | 0.100 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2012 | 165 | 0.100 |
Why?
|
| Neoplasm Metastasis | 1 | 2015 | 1056 | 0.100 |
Why?
|
| Neoplasm Invasiveness | 1 | 2012 | 552 | 0.090 |
Why?
|
| Virus Internalization | 2 | 2020 | 39 | 0.090 |
Why?
|
| Inflammation | 1 | 2016 | 920 | 0.090 |
Why?
|
| Gene Regulatory Networks | 1 | 2012 | 296 | 0.090 |
Why?
|
| Membrane Proteins | 1 | 2016 | 1196 | 0.090 |
Why?
|
| Homeodomain Proteins | 1 | 2012 | 536 | 0.080 |
Why?
|
| Cell Differentiation | 3 | 2020 | 1458 | 0.080 |
Why?
|
| Gene Expression Regulation | 1 | 2016 | 1920 | 0.080 |
Why?
|
| SOX9 Transcription Factor | 1 | 2021 | 23 | 0.050 |
Why?
|
| Viral Tropism | 1 | 2020 | 4 | 0.050 |
Why?
|
| Peptidyl-Dipeptidase A | 1 | 2020 | 32 | 0.050 |
Why?
|
| Heterografts | 1 | 2020 | 98 | 0.050 |
Why?
|
| Rabbits | 1 | 2021 | 636 | 0.050 |
Why?
|
| Drug Approval | 1 | 2020 | 62 | 0.050 |
Why?
|
| Autopsy | 1 | 2020 | 116 | 0.050 |
Why?
|
| United States Food and Drug Administration | 1 | 2020 | 127 | 0.050 |
Why?
|
| Immune System | 1 | 2021 | 93 | 0.050 |
Why?
|
| Child | 2 | 2021 | 6927 | 0.050 |
Why?
|
| Species Specificity | 1 | 2021 | 678 | 0.040 |
Why?
|
| Hepatocytes | 1 | 2020 | 127 | 0.040 |
Why?
|
| In Vitro Techniques | 1 | 2020 | 989 | 0.040 |
Why?
|
| Pancreas | 1 | 2020 | 239 | 0.040 |
Why?
|
| Enteroendocrine Cells | 1 | 2017 | 6 | 0.040 |
Why?
|
| Gentamicins | 1 | 2017 | 19 | 0.040 |
Why?
|
| Goblet Cells | 1 | 2017 | 19 | 0.040 |
Why?
|
| Heterocyclic Compounds, 3-Ring | 1 | 2017 | 26 | 0.040 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2017 | 78 | 0.040 |
Why?
|
| Biopsy | 1 | 2021 | 1163 | 0.040 |
Why?
|
| Mice, Knockout | 1 | 2021 | 1924 | 0.040 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2017 | 316 | 0.040 |
Why?
|
| Wnt Signaling Pathway | 1 | 2017 | 91 | 0.040 |
Why?
|
| Microscopy, Confocal | 1 | 2017 | 268 | 0.040 |
Why?
|
| Histone Deacetylase 1 | 1 | 2016 | 13 | 0.040 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2017 | 273 | 0.040 |
Why?
|
| Sirolimus | 1 | 2017 | 169 | 0.030 |
Why?
|
| DNA (Cytosine-5-)-Methyltransferases | 1 | 2016 | 55 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2021 | 1801 | 0.030 |
Why?
|
| Blotting, Western | 1 | 2017 | 782 | 0.030 |
Why?
|
| Cell Line | 1 | 2020 | 2468 | 0.030 |
Why?
|
| Gene Silencing | 1 | 2016 | 172 | 0.030 |
Why?
|
| Flow Cytometry | 1 | 2017 | 679 | 0.030 |
Why?
|
| Gene Knockdown Techniques | 1 | 2016 | 236 | 0.030 |
Why?
|
| Phenotype | 1 | 2021 | 2378 | 0.030 |
Why?
|
| Infant, Newborn | 1 | 2021 | 2380 | 0.030 |
Why?
|
| Cell Lineage | 1 | 2016 | 273 | 0.030 |
Why?
|
| Germ-Line Mutation | 1 | 2017 | 329 | 0.030 |
Why?
|
| Infant | 1 | 2021 | 3047 | 0.030 |
Why?
|
| Stress, Physiological | 1 | 2016 | 227 | 0.030 |
Why?
|
| Pandemics | 1 | 2020 | 740 | 0.030 |
Why?
|
| Child, Preschool | 1 | 2021 | 3612 | 0.030 |
Why?
|
| Prognosis | 1 | 2021 | 3679 | 0.030 |
Why?
|
| Immunohistochemistry | 1 | 2017 | 1753 | 0.030 |
Why?
|
| Promoter Regions, Genetic | 1 | 2016 | 937 | 0.030 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2021 | 2271 | 0.030 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2016 | 683 | 0.030 |
Why?
|
| Epigenesis, Genetic | 1 | 2016 | 479 | 0.030 |
Why?
|
| Base Sequence | 1 | 2016 | 2330 | 0.030 |
Why?
|
| Molecular Sequence Data | 1 | 2016 | 3030 | 0.020 |
Why?
|
| Risk Factors | 1 | 2021 | 5417 | 0.020 |
Why?
|
| United States | 1 | 2020 | 6672 | 0.020 |
Why?
|
| Adolescent | 1 | 2021 | 8981 | 0.020 |
Why?
|
| Male | 2 | 2021 | 40966 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2021 | 8489 | 0.020 |
Why?
|
| Female | 2 | 2021 | 44533 | 0.020 |
Why?
|
| Aged | 1 | 2021 | 18415 | 0.020 |
Why?
|
| Middle Aged | 1 | 2021 | 25028 | 0.010 |
Why?
|